Pharma Mar | PHM - Interest Expense On Debt

Stock Price
80.10
Daily Change
1.40 1.78%
Monthly
-0.62%
Yearly
-16.69%
Q1 Forecast
77.09

Pharma Mar reported EUR117K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Akebia Therapeutics 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 0 0 Dec/2023
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
IQVIA Holdings USD 193M 4M Dec/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Moderna USD 12.14B 12.13B Sep/2025
Organon & Co USD 128M 3M Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Revvity USD 23.51M 742K Dec/2025
Tectonic Therapeutic USD 277M 276.98M Sep/2025
Viatris USD 119.6M 3M Sep/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025